Theodore G. Liou

8.0k citations

77 papers · 5.3k indexed · 4 hit papers · h-index 25

Pulmonary and Respiratory Medicine top 0.2%
- Cystic Fibrosis Research Advances 40
- Pulmonary Hypertension Research and Treatments 14
- Neonatal Respiratory Health Research 12
- Tracheal and airway disorders 8
- Respiratory Support and Mechanisms 5
- Chronic Obstructive Pulmonary Disease (COPD) Research 5
Cardiology and Cardiovascular Medicine top 1%
- Cardiovascular Issues in Pregnancy 6
Genetics top 1%
Transplantation top 5%
Hepatology top 2%
Surgery
- Transplantation: Methods and Outcomes 9

Co-authors: Michael D. McGoon Robyn J. Barst Adaani Frost Dave P. Miller Frederick R. Adler Raymond L. Benza David B. Badesch C. Gregory Elliott
Cited by: Pulmonary and Respiratory Medicine Cardiology and Cardiovascular Medicine Genetics
Partner nations: United States United Kingdom Canada

In The Last Decade

Theodore G. Liou

75 papers receiving 5.2k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2023 Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study
2010 Predicting Survival in Pulmonary Arterial Hypertension
2009 Pulmonary Arterial Hypertension
2001 Predictive 5-Year Survivorship Model of Cystic Fibrosis

Peers

Countries citing papers authored by Theodore G. Liou

Since Specialization

Citations

This map shows the geographic impact of Theodore G. Liou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodore G. Liou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodore G. Liou more than expected).

Fields of papers citing papers by Theodore G. Liou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theodore G. Liou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodore G. Liou. The network helps show where Theodore G. Liou may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Theodore G. Liou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Theodore G. Liou Line = papers co-authored together Theodore G. Liou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impact of CFTR Modulators on Longitudinal Cystic Fibrosis Survival and Mortality: Review and Secondary Analysis Jaime Rubin,Craig J. McKinnon,Gabriel Pedra,Devon A. Morgan,Kevin Zweig,Theodore G. Liou	2025	1
2	Efficacy and safety of LAU-7b in a Phase 2 trial in adults with cystic fibrosis Michael W. Konstan,Deepika Polineni,James F. Chmiel,Lara Bilodeau,Peter G. Middleton,Elias Matouk,Jean‐Marie Houle,Radu Pislariu,Patrick Colin,Irenej Kianicka,Diane Potvin,Danuta Radzioch,Tom Kotsimbos,Jonathan B. Zuckerman,Samya Z. Nasr,Theodore G. Liou,Larry C. Lands	2024	0
3	Predicting weight gain in patients with cystic fibrosis on triple combination modulator Kelly L. Stewart,Rhonda D. Szczesniak,Theodore G. Liou	2024	6
4	Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis Nicole Mayer-Hamblett,Alex H. Gifford,Margaret Kloster,Renee Russell,Andrew T. Braun,Ronald L. Gibson,Jordana E. Hoppe,Raksha Jain,Rachel W. Linnemann,Theodore G. Liou,Jerimiah Lysinger,Carlos Milla,Kristin A. Riekert,G. Sawicki,J.C. Young,David P. Nichols	2024	7
5	Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical studybreakdown → Steven M. Rowe,Jonathan B. Zuckerman,Daniel Dorgan,Jorge Lascano,Karen McCoy,Manu Jain,Michael S. Schechter,Sherstin T. Lommatzsch,V. Indihar,Noah Lechtzin,Kimberly McBennett,Caroline Callison,Cynthia D. Brown,Theodore G. Liou,Kelvin D. MacDonald,Samya Z. Nasr,Susan Bodie,M. Vaughn,Eric B. Meltzer,Ann Barbier	2023	82
6	MS1 VALIDATION OF MODELED 5-YEAR SURVIVAL OUTCOMES AMONG PATIENTS WITH CYSTIC FIBROSIS (CF) TREATED WITH THE CF TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATOR (CFTRM) IVACAFTOR USING US CF FOUNDATION PATIENT REGISTRY (USCFFPR) DATA Lisa J. McGarry,A. Lopez,Conor Chandler,C. Pelligra,Zahra Alkhateeb,Jaime Rubin,Theodore G. Liou	2020	2
7	A multi-scale approach to study biochemical and biophysical aspects of resveratrol on diesel exhaust particle-human primary lung cell interaction Wei Zhang,Qifei Li,Mingjie Tang,Han Zhang,Xiaoping Sun,Sige Zou,Judy L. Jensen,Theodore G. Liou,Anhong Zhou	2019	211
8	Refinement of metabolite detection in cystic fibrosis sputum reveals heme correlates with lung function decline Nathaniel R. Glasser,Ryan C. Hunter,Theodore G. Liou,Dianne K. Newman	2019	15
9	The Dynamics of Disease Progression in Cystic Fibrosis Frederick R. Adler,Theodore G. Liou	2016	17
10	Toxicity effects of short term diesel exhaust particles exposure to human small airway epithelial cells (SAECs) and human lung carcinoma epithelial cells (A549) Mingjie Tang,Qifei Li,Lifu Xiao,Yanping Li,Judy L. Jensen,Theodore G. Liou,Anhong Zhou	2012	22
11	Predicting Survival in Pulmonary Arterial Hypertensionbreakdown → Raymond L. Benza,Dave P. Miller,Mardi Gomberg‐Maitland,Robert P. Frantz,Aimee J. Foreman,Christopher S. Coffey,Adaani Frost,Robyn J. Barst,David B. Badesch,C. Gregory Elliott,Theodore G. Liou,Michael D. McGoon	2010	1139
12	Spirometry Theodore G. Liou,Richard E. Kanner	2009	33
13	Pediatric Lung Transplantation for Cystic Fibrosis Theodore G. Liou,Barbara C. Cahill	2008	4
14	Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension Michael D. McGoon,Abby Krichman,Harrison W. Farber,Robyn J. Barst,Gary E. Raskob,Theodore G. Liou,Dave P. Miller,Kathy Feldkircher,Scott Giles	2008	102
15	Use of Lung Transplantation Survival Models to Refine Patient Selection in Cystic Fibrosis Theodore G. Liou,Frederick R. Adler,David Huang	2005	89
16	Epidemiology of cystic fibrosis-related diabetes Bruce C. Marshall,Steven M. Butler,MARCIA L. STODDARD,Antoinette Moran,Theodore G. Liou,Wayne J. Morgan	2005	239
17	Selection of patients with cystic fibrosis for lung transplantation Theodore G. Liou,Barbara C. Cahill,Frederick R. Adler,Bruce C. Marshall	2002	7
18	CF-related diabetes mellitus: The ESCF experience Bruce C. Marshall,Steven M. Butler,MARCIA L. STODDARD,Antoinette Moran,Theodore G. Liou,Wayne J. Morgan	2000	1
19	Elusiveness of ideal approach to Pseudomona aeruginosa infection complicating cystic fibrosis Bruce C. Marshall,Theodore G. Liou	2000	1
20	Nonisotropic Enzyme-Inhibitor Interactions: A Novel Nonoxidative Mechanism for Quantum Proteolysis by Human Neutrophils Theodore G. Liou,E. J. Campbell	1995	82

About Theodore G. Liou

Theodore G. Liou is a scholar working on Pulmonary and Respiratory Medicine, Transplantation and Speech and Hearing, having authored 77 papers that have together received 5.3k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (40 papers), Pulmonary Hypertension Research and Treatments (14 papers), Neonatal Respiratory Health Research (12 papers), Transplantation: Methods and Outcomes (9 papers), Tracheal and airway disorders (8 papers), Cardiovascular Issues in Pregnancy (6 papers), Respiratory Support and Mechanisms (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.4k citations), Cardiology and Cardiovascular Medicine (1.8k citations) and Genetics (615 citations). Theodore G. Liou has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Michael D. McGoon, Robyn J. Barst, Adaani Frost, Dave P. Miller, Frederick R. Adler, Raymond L. Benza, David B. Badesch, C. Gregory Elliott, Bruce C. Marshall and Barbara C. Cahill.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact